Midterm results on a new self-expandable covered stent combined with branched stent grafts: Insights from a multicenter Italian registry.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
06 2023
Historique:
received: 13 12 2022
revised: 07 02 2023
accepted: 14 02 2023
medline: 26 5 2023
pubmed: 24 2 2023
entrez: 23 2 2023
Statut: ppublish

Résumé

To investigate the technical periprocedural and midterm outcomes of endovascular repairs with multibranched endovascular repair or iliac branch devices combined with a new self-expanding covered stent. The COvera in BRAnch registry is a physician-initiated, multicenter, ambispective, observational registry (ClinicalTrials.gov Identifier: NCT04598802) enrolling patients receiving a multibranched endovascular repair or iliac branch devices procedure mated with Bard Covera Plus (Tempe, AZ) covered stent, designed to evaluate the outcomes of the covered stent mated with patient-specific and off-the-shelf branched stent graft. Primary end points were technical success, branch instability, and freedom from aortic and branch-related reintervention within 30 days and at follow-up. Preoperative characteristics, comorbidities, and outcomes definitions were graded according to the Society for Vascular Surgery reporting standards. Two hundred eighty-four patients (76 years; range, 70-80 years; 79% males) in 24 centers were enrolled for a total of 708 target vessels treated. The covered stents were mated with an off-the-shelf graft in 556 vessels (79%) and a custom-made graft in 152 (21%). Three hundred seven adjunctive relining stents in 277 vessels (39%) were deployed, of which 116 (38%) were proximal, 66 (21%) intrastent, and 125 (41%) distal. Adjunctive relining stent placement was more frequent when landing in a vessel branch instead of the main trunk (59% vs 39%; P = .031), performing a percutaneous access (49% vs 35%; P < .001), using a stent with a diameter of 8 mm or greater (44% vs 36%; P = .032) and a length of 80 mm or greater (65% vs 55%; P = .005), when a post-dilatation was not performed (45% vs 29%; P < .001) and when an inner branch configuration was used (55% vs 35%; P < .001). Perioperative technical bridging success was 98%. Eight patients (3%) died in the perioperative period. Two deaths (1%) were associated with renal branch occlusion followed by acute kidney injury and paraplegia. Follow-up data were available for 638 vessels (90%) at a median of 32 months (Q1, Q3, 21, 46). Branch instability was reported in 1% of branches. Forty-six patients (17%) died during follow-up, nine (3%) of them owing to aortic-related causes. Primary patency rates at 1, 2, and 3 years were 99% (581/587), 99% (404/411), and 97% (272/279), respectively. Branch instability was associated with patient-specific devices (9% vs 4%; P = .014) and intrastent adjunctive stent placement (12% vs 2%; P = .003), especially when a bare metal balloon-expandable stent was used (25% vs 3%; P < .001). The use of this new self-expanding covered stent mated with branched endografts proved to be safe and feasible with high technical procedural success rates. Low rates of branch instability were observed at midterm follow-up. Comparative studies with other commercially available covered stents are warranted.

Identifiants

pubmed: 36822256
pii: S0741-5214(23)00375-0
doi: 10.1016/j.jvs.2023.02.007
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04598802']

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1598-1606.e3

Investigateurs

Domenico Angiletta (D)
Roberto Chiesa (R)
Luca Di Marzo (L)
Loris Flora (L)
Stefano Gennai (S)
Rocco Giudice (R)
Massimo Lenti (M)
Nicola Leone (N)
Mario D'Oria (M)
Sandro Lepidi (S)
Andrea Melloni (A)
Luca Mezzetto (L)
Stefano Michelagnoli (S)
Bruno Migliara (B)
Domenico Milite (D)
Davide Pacini (D)
Enzo Palazzo (E)
Alberto Pecchio (A)
Alberto Pegorer Matteo (A)
Paolo Perini (P)
Michele Piazza (M)
Giovanni Pratesi (G)
Sonia Ronchey (S)
Nicola Spadoni (N)
Nicola Tusini (N)
Fabio Verzini (F)

Informations de copyright

Copyright © 2023 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Luca Bertoglio (L)

Division of vascular Surgery, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: luca.bertoglio@unibs.it.

Alessandro Grandi (A)

Division of vascular Surgery, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Gian Franco Veraldi (GF)

Division Vascular Surgery, Integrated University Hospital of Verona, Verona, Italy.

Raffaele Pulli (R)

Division Vascular Surgery, Department of Cardiothoracic Surgery, University of Bari School of Medicine, Bari, Italy.

Michele Antonello (M)

Vascular and Endovascular Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.

Stefano Bonvini (S)

Department of Vascular Surgery, Santa Chiara Hospital, Trento, Italy.

Giacomo Isernia (G)

Unit of Vascular and Endovascular Surgery, Santa Maria della Misericordia Hospital, Perugia, Italy.

Raffaello Bellosta (R)

Division of vascular Surgery, Cardiovascular Department, Poliambulanza Foundation, Brescia, Italy.

Francesco Buia (F)

Pediatric and Adult Cardio-Thoracovascular, Onchoematologic and Emergencies Radiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Roberto Silingardi (R)

Division of vascular Surgery, Ospedale Civile di Baggiovara, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH